Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein

Biochemical and Biophysical Research Communications

Volumn 386, Issue 1, 2009, Pages 35-39

  Ren, Li Nan ^a,c   Li, Qing Fang ^b   Xiao, Feng Jun ^b   Yan, Jun ^b   Yang, Yue Feng ^b   Wang, Li Sheng ^b   Guo, Xiao Zhong ^c   Wang, Hua ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Apoptosis; EG VEGF; Pancreatic cancer; Signal pathway

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN MCL 1; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, G-PROTEIN-COUPLED; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

AGOUTI PACA;

EID: 67649170382     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.149     Document Type: Article

References (29)

1. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J. Clin. 46 (1996) 5-27
2. Poston G.J., Gillespie J., and Guillou P.J. Biology of pancreatic cancer. Gut 32 (1991) 800-812
3. Mangray S., and King T.C. Molecular pathobiology of pancreatic adenocarcinoma. Front. Biosci. 3 (1998) 1148-1160
4. Okada H., and Mak T.W. Pathways of apoptotic and non-apoptotic death in tumor cells. Nat. Rev. Cancer 4 (2004) 592-603
5. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., Frantz G., Rangell L., DeGuzman L., Keller G.A., Peale F., Gurney A., Hillan K.J., and Ferrara N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412 (2001) 877-884
6. Ngan E.S.W., Lee K.Y., Yeung W.S.B., and Ngan H.Y.S. Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma. Endocrinology 147 (2007) 88-95
7. LeCouter J., Lin R., Tejada M., Frantz G., Peale F., Hillan K., and Ferrara N. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc. Natl. Acad. Sci. USA 100 (2003) 2685-2690
8. Kisliouk T., Levy N., Hurwitz A., and Meidan R. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J. Clin. Endocrinol. Metab. 88 (2003) 3700-3707
9. Morales A., Vilchis F., Chavez B., Chan C., Robles-Diaz G., and Diaz-Sanchez V. Expression and localization of endocrine gland-derived vascular endothelial growth factor in human pancreas and pancreatic adenocarcinoma. J. Steroid. Biochem. Mol. Biol. 107 (2007) 37-41
10. Goi T., Fujioka M., and Satoh Y. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res. 64 (2004) 1906-1910
11. Li Q., Xu B., Fu L., and Hao X. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 25 (2006) 403-409
12. Dorsch M., Qiu Y., Soler D., Frank N., Duonq T., Goodearl A., O'Neil S., Lora J., and Fraser C.C. PK1/EG-VEGF induces monocyte differentiation and activation. J. Leukoc. Biol. 78 (2005) 426-434
13. LeCouter J., Zlot C., Tejada M., Peale F., and Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. USA 101 (2004) 16813-16818
14. Lin R., LeCouter J., Kowalski J., and Ferrara N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J. Biol. Chem. 277 (2002) 8724-8729
15. Li M., Bullock C.M., Knauer D.J., Ehlert F.J., and Zhou Q.Y. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol. Pharmacol. 59 (2001) 692-698
16. Kaser A., Winklmayr M., Lepperdinger G., and Kreil G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep. 4 (2003) 469-473
17. Miyamoto Y., Hosotani R., Wada M., Lee J., Koshiba T., Fujimoto K., Tsuji S., Nakajima S., Doi R., Kato M., Shimada Y., and Imamura M. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 56 (1999) 73-82
18. Akgul C., Turner P., White M., and Edwards S. Functional analysis of the human MCL-1 gene. Cell. Mol. Life Sci. 57 (2000) 684-691
19. Kozopas K., Yang T., Buchan H., Zhou P., and Craig R. MCL1, a gene expressed programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 90 (1993) 3516-3520
20. Ghobrial I.M., Witzig T.E., and Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55 (2005) 178-194
21. Ngan E.S., Sit F.Y., Lee K., Miao X., Yuan Z., Wang W., Nichools J.M., Wong K.K., Garcia-Barcelo M., Lui V.C., and Tam P.K. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin. Cancer Res. 13 (2007) 868-875
22. Ngan E.S., and Tam P.K. Prokineticin-signaling pathway. Int. J. Biochem. Cell Biol. 40 (2008) 1679-1684
23. Lin X., Morgan-Lappe S., Huang X., Li L., Zakula D.M., Vernetti L.A., Fesik S.W., and Shen Y. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene 26 (2007) 3972-3979
24. Cavarretta I.T., Neuwirt H., Untergasser G., Moser P.L., Zaki M.H., Steiner H., Rumpold H., Fuchs D., Hobisch A., Nemeth J.A., and Nemeth Z. The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1. Oncogene 26 (2007) 2822-2832
25. Li Q.F., Wu C.T., Guo Q., Wang H., and Wang L.S. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. Biochem. Biophys. Res. Commun. 371 (2008) 159-162
26. Li Y., and Sarkar F.H. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin. Cancer Res. 8 (2002) 2369-2377
27. Hoffmann P., Feige J.J., and Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 147 (2006) 1675-1684
28. Urayama K., Guilini C., Messaddeq N., Hu K., Steenman M., Kurose H., Ert G., and Nebigil C.G. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. FASEB J. 21 (2007) 2980-2993
29. Lin D.C., Bullock C.M., Ehlert F.J., Chen J.L., Tian H., and Zhou Y.Q. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem. 277 (2002) 19276-19280